{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,15]],"date-time":"2024-08-15T09:51:19Z","timestamp":1723715479082},"reference-count":0,"publisher":"Edizioni Minerva Medica","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Minerva Endocrinol"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.23736\/s0391-1977.17.02638-4","type":"journal-article","created":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:24:24Z","timestamp":1625225064000},"source":"Crossref","is-referenced-by-count":7,"title":["Ovarian hyperstimulation syndrome management strategies: where are we going?"],"prefix":"10.23736","volume":"43","author":[{"given":"Ashley M.","family":"Eskew","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenan R.","family":"Omurtag","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"17149","container-title":["Minerva Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.minervamedica.it\/pdf.php?cod=R07Y2018N01A0050","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,2]],"date-time":"2021-07-02T11:24:32Z","timestamp":1625225072000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.minervamedica.it\/index2.php?show=R07Y2018N01A0050"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":0,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.23736\/s0391-1977.17.02638-4","relation":{},"ISSN":["2724-6507","2724-6116"],"issn-type":[{"value":"2724-6507","type":"print"},{"value":"2724-6116","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1]]}}}